F 0641
Ensure each resident receives an accurate assessment.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility failed to accurately document the health condition related
to medical condition for two of five sampled residents (Resident 9 and Resident 196), using the Minimum
Data Set ((MDS - a tool used to assess and plan care of residents in a nursing facility) when:
Residents Affected - Few
1. For Resident 9 - had a missing diagnosis for anxiety.
2. For Resident 196 - had a missing diagnosis for depression.
This facility failure resulted in the facility reporting inaccurate data to Centers for Medicare & Medicaid
Services (CMS).
Findings:
During a review of the facility's policy and procedure (P&P) titled, Resident Assessment Instrument (RAI),
dated 10/2019, the P&P indicated, Medical record sources for physician diagnoses include progress notes,
the most recent history and physical, transfer documents, discharge summaries, diagnosis/problem list, and
other resources as available.
1. During a review of Resident 9's Face Sheet (FS), dated 4/23, the FS indicated, Resident 9 had a
diagnosis of Unspecified Anxiety Disorder.
During a review of the Physician's Order (PO), dated 4/19/23, the PO indicated, Resident 9 is to be given
Lorazepam concentrates 2 milligrams/milliliter (mg/ml), 0.1 ml orally (by mouth) every six hours as needed
for Anxiety manifested by restlessness and/or shortness of breath.
During a review of the Physician Order and Informed Consent Verification Form (POICVF), dated 4/23, the
POICVF indicated, the informed consent for the Lorazepam for diagnosis of Anxiety was obtained from
Resident 9's responsible party.
During a review of Resident 9's Care Plan (CP) - (a plan developed by the facility to identify resident's
needs care and needs), dated 2/23, the CP indicated, Resident 9 uses anti-anxiety medication related to
anxiety disorder.
During a concurrent interview and record review, on 4/27/23, at 10:30 a.m., with the Director of Nursing
(DON), Resident 9's most recent MDS section I, dated 2/17/23 was reviewed. The MDS indicated, a
missing diagnosis for Anxiety. The DON stated, I already knew my deficiency. I missed the diagnosis for
Anxiety. The DON further stated, I should have coded it.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
555857
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555857
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/27/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oakview Skilled Nursing
3557 Campus Drive
Thousand Oaks, CA 91360
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
Level of Harm - Minimal harm
or potential for actual harm
2. During a review of Resident 196's PO, dated 4/10/23, the PO indicated, Resident 196 is to be given
Trazodone 50 mg by mouth at bedtime for Depression resulting in insomnia .
During a review of the POICVF, dated 4/10, the POICVF indicated, the informed consent for Trazodone for
the diagnosis of Depression was obtained from Resident 196.
Residents Affected - Few
During a review of Resident 196's CP, dated 2/23, the CP indicated, Resident 196 uses antidepressant
medication related to diagnosis of Depression.
During a concurrent interview and record review, on 4/27/23, at 10:30 a.m., with the DON, Resident 196's
MDS section I, dated 4/17/23 was reviewed. The MDS indicated, a missing diagnosis for Depression. The
DON acknowledged and stated, There was no documentation coding for Depression diagnosis in section I.
The DON further stated, I missed documenting the diagnosis .It was my mistake.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555857
If continuation sheet
Page 2 of 2